197 related articles for article (PubMed ID: 36892668)
1. Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence.
Tamura R; Iwanami A; Ohara K; Nishimoto M; Pareira ES; Miwa T; Tsuzaki N; Kuranari Y; Morimoto Y; Toda M; Okano H; Nakamura M; Yoshida K; Sasaki H
Brain Tumor Pathol; 2023 Apr; 40(2):109-123. PubMed ID: 36892668
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of histopathological presentation of pilocytic astrocytoma - diagnostic pitfalls. A review.
Matyja E; Grajkowska W; Stępień K; Naganska E
Folia Neuropathol; 2016; 54(3):197-211. PubMed ID: 27764513
[TBL] [Abstract][Full Text] [Related]
3. Genetic and histopathological associations with outcome in pediatric pilocytic astrocytoma.
Cler SJ; Skidmore A; Yahanda AT; Mackey K; Rubin JB; Cluster A; Perkins S; Gauvain K; King AA; Limbrick DD; McEvoy S; Park TS; Smyth MD; Mian AY; Chicoine MR; Dahiya S; Strahle JM
J Neurosurg Pediatr; 2022 May; 29(5):504-512. PubMed ID: 35148515
[TBL] [Abstract][Full Text] [Related]
4. Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas.
Horbinski C; Hamilton RL; Nikiforov Y; Pollack IF
Acta Neuropathol; 2010 May; 119(5):641-9. PubMed ID: 20044755
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
[TBL] [Abstract][Full Text] [Related]
6. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
[TBL] [Abstract][Full Text] [Related]
7. Novel Surgical and Radiologic Risk Factors for Progression or Recurrence of Pediatric Pilocytic Astrocytoma.
Villanueva KG; Rea ND; Krieger MD
Pediatr Neurosurg; 2019; 54(6):375-385. PubMed ID: 31593969
[TBL] [Abstract][Full Text] [Related]
8. Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas.
Krieger MD; Gonzalez-Gomez I; Levy ML; McComb JG
Pediatr Neurosurg; 1997 Jul; 27(1):1-11. PubMed ID: 9486830
[TBL] [Abstract][Full Text] [Related]
9. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
[No Abstract] [Full Text] [Related]
11. Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.
Rodriguez FJ; Brosnan-Cashman JA; Allen SJ; Vizcaino MA; Giannini C; Camelo-Piragua S; Webb M; Matsushita M; Wadhwani N; Tabbarah A; Hamideh D; Jiang L; Chen L; Arvanitis LD; Alnajar HH; Barber JR; Rodríguez-Velasco A; Orr B; Heaphy CM
Brain Pathol; 2019 Jan; 29(1):126-140. PubMed ID: 30192422
[TBL] [Abstract][Full Text] [Related]
12. Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.
Roth JJ; Fierst TM; Waanders AJ; Yimei L; Biegel JA; Santi M
J Neuropathol Exp Neurol; 2016 Apr; 75(4):306-15. PubMed ID: 26945035
[TBL] [Abstract][Full Text] [Related]
13. Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours.
Métais A; Bouchoucha Y; Kergrohen T; Dangouloff-Ros V; Maynadier X; Ajlil Y; Carton M; Yacoub W; Saffroy R; Figarella-Branger D; Uro-Coste E; Sevely A; Larrieu-Ciron D; Faisant M; Machet MC; Wahler E; Roux A; Benichi S; Beccaria K; Blauwblomme T; Boddaert N; Chrétien F; Doz F; Dufour C; Grill J; Debily MA; Varlet P; Tauziède-Espariat A
Acta Neuropathol; 2023 Jan; 145(1):83-95. PubMed ID: 36264505
[TBL] [Abstract][Full Text] [Related]
14. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution.
Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243
[TBL] [Abstract][Full Text] [Related]
15. Pilocytic astrocytoma: a retrospective study of 32 cases.
Cyrine S; Sonia Z; Mounir T; Badderedine S; Kalthoum T; Hedi K; Moncef M
Clin Neurol Neurosurg; 2013 Aug; 115(8):1220-5. PubMed ID: 23265563
[TBL] [Abstract][Full Text] [Related]
16. High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas.
Hatanpaa KJ; Hu T; Vemireddy V; Foong C; Raisanen JM; Oliver D; Hiemenz MC; Burns DK; White CL; Whitworth LA; Mickey B; Stegner M; Habib AA; Fink K; Maher EA; Bachoo RM
J Neurooncol; 2014 Mar; 117(1):183-189. PubMed ID: 24519516
[TBL] [Abstract][Full Text] [Related]
17. Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas.
Horbinski C; Hamilton RL; Lovell C; Burnham J; Pollack IF
Brain Pathol; 2010 May; 20(3):581-8. PubMed ID: 19832838
[TBL] [Abstract][Full Text] [Related]
18. Methylation profiling of paediatric pilocytic astrocytoma reveals variants specifically associated with tumour location and predictive of recurrence.
Sexton-Oates A; Dodgshun A; Hovestadt V; Jones DTW; Ashley DM; Sullivan M; MacGregor D; Saffery R
Mol Oncol; 2018 Aug; 12(8):1219-1232. PubMed ID: 28388012
[TBL] [Abstract][Full Text] [Related]
19. Pilomyxoid astrocytomas: a short review.
Kulac I; Tihan T
Brain Tumor Pathol; 2019 Apr; 36(2):52-55. PubMed ID: 30945015
[TBL] [Abstract][Full Text] [Related]
20. Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations.
Liu XY; Gerges N; Korshunov A; Sabha N; Khuong-Quang DA; Fontebasso AM; Fleming A; Hadjadj D; Schwartzentruber J; Majewski J; Dong Z; Siegel P; Albrecht S; Croul S; Jones DT; Kool M; Tonjes M; Reifenberger G; Faury D; Zadeh G; Pfister S; Jabado N
Acta Neuropathol; 2012 Nov; 124(5):615-25. PubMed ID: 22886134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]